Gelişmiş Arama

Basit öğe kaydını göster

A Report of Rabbit Syndrome Who Benefited from Sigma 1 Agonist Fluvoxamine

dc.contributor.authorAlbayrak, Yakup
dc.contributor.authorBeyazyüz, Murat
dc.contributor.authorAbbak, Özlem
dc.contributor.authorAltındağ, Ece
dc.date.accessioned2022-05-11T14:41:07Z
dc.date.available2022-05-11T14:41:07Z
dc.date.issued2019
dc.identifier.issn1738-1088
dc.identifier.issn2093-4327
dc.identifier.urihttps://doi.org/10.9758/cpn.2019.17.1.134
dc.identifier.urihttps://hdl.handle.net/20.500.11776/9068
dc.description.abstractRabbit Syndrome is an uncommon side effect of antipsychotic treatment. Although it is usually associated with typical antipsychotics, it can also be related to atypical antipsychotics. Anticholinergics are the most accepted treatment approach in treating Rabbit Syndrome. Fluvoxamine is a member of selective serotonin reuptake inhibitors and it is a potent agonist of sigma 1 receptors. In this article, we report a Rabbit Syndrome case who has benefited from fluvoxamine, in terms of both depressive disorder and Rabbit Syndrome; and present the data on the effects of sigma 1 agonist fluvoxamine on numerous movement disorders.en_US
dc.language.isoengen_US
dc.publisherKorean Coll Neuropsychopharmacologyen_US
dc.identifier.doi10.9758/cpn.2019.17.1.134
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectRabbit syndromeen_US
dc.subjectSigma receptorsen_US
dc.subjectSide effecten_US
dc.subjectFluvoxamineen_US
dc.subjectSerotonin Reuptake Inhibitorsen_US
dc.subjectClinical-Implicationsen_US
dc.subjectTardive-Dyskinesiaen_US
dc.subjectReceptor Agonistsen_US
dc.subjectChaperoneen_US
dc.subjectLigandsen_US
dc.subjectCortexen_US
dc.subjectBrainen_US
dc.subjectScaleen_US
dc.titleA Report of Rabbit Syndrome Who Benefited from Sigma 1 Agonist Fluvoxamineen_US
dc.typeeditorialMaterialen_US
dc.relation.ispartofClinical Psychopharmacology and Neuroscienceen_US
dc.departmentFakülteler, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, Ruh Sağlığı ve Hastalıkları Ana Bilim Dalıen_US
dc.authorid0000-0002-5770-344X
dc.identifier.volume17en_US
dc.identifier.issue1en_US
dc.identifier.startpage134en_US
dc.identifier.endpage138en_US
dc.institutionauthorAlbayrak, Yakup
dc.institutionauthorBeyazyüz, Murat
dc.institutionauthorAbbak, Özlem
dc.institutionauthorAltındağ, Ece
dc.relation.publicationcategoryDiğeren_US
dc.authorscopusid29067508300
dc.authorscopusid27967486000
dc.authorscopusid57195962064
dc.authorscopusid57195959817
dc.authorwosidBEYAZYUZ, MURAT/ABA-7934-2020
dc.authorwosidAlbayrak, Yakup/ABA-7651-2020
dc.identifier.wosWOS:000455924800016en_US
dc.identifier.scopus2-s2.0-85060800970en_US
dc.identifier.pmid30690950en_US


Bu öğenin dosyaları:

Thumbnail
Ad:
9068.pdf
Boyut:
186.9Kb
Biçim:
PDF
Açıklama:
Tam Metin / Full Text
Göster/Aç

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster